Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zic2
|
ENSMUSG00000061524.8 | zinc finger protein of the cerebellum 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr14_122479141_122479308 | Zic2 | 1124 | 0.338696 | 0.72 | 1.0e-10 | Click! |
chr14_122475443_122476757 | Zic2 | 665 | 0.435336 | 0.71 | 2.3e-10 | Click! |
chr14_122481884_122483266 | Zic2 | 4475 | 0.123539 | 0.69 | 1.3e-09 | Click! |
chr14_122478089_122479067 | Zic2 | 478 | 0.680259 | 0.67 | 4.2e-09 | Click! |
chr14_122477033_122477655 | Zic2 | 756 | 0.475598 | 0.65 | 1.5e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr14_28508967_28511864 | 8.24 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr12_33928070_33929277 | 6.63 |
Gm40383 |
predicted gene, 40383 |
217 |
0.53 |
chr9_112118202_112119292 | 6.58 |
Mir128-2 |
microRNA 128-2 |
36 |
0.99 |
chr5_37821115_37822599 | 6.45 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr1_19215607_19218714 | 6.25 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr13_72629730_72632045 | 6.09 |
Irx2 |
Iroquois homeobox 2 |
1062 |
0.51 |
chr10_73096427_73097649 | 6.05 |
Pcdh15 |
protocadherin 15 |
2304 |
0.33 |
chr4_139832357_139834219 | 5.88 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr2_49619321_49620607 | 5.80 |
Kif5c |
kinesin family member 5C |
666 |
0.78 |
chr6_77243534_77244121 | 5.75 |
Lrrtm1 |
leucine rich repeat transmembrane neuronal 1 |
905 |
0.69 |
chr6_101198088_101199306 | 5.58 |
Gm26911 |
predicted gene, 26911 |
39 |
0.89 |
chr5_120425610_120425983 | 5.54 |
Lhx5 |
LIM homeobox protein 5 |
5903 |
0.14 |
chr5_27048872_27050274 | 5.53 |
Dpp6 |
dipeptidylpeptidase 6 |
180 |
0.97 |
chr11_115486285_115486665 | 5.40 |
Nt5c |
5',3'-nucleotidase, cytosolic |
4727 |
0.09 |
chr13_83727321_83728283 | 5.28 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr12_73042328_73042946 | 5.16 |
Six1 |
sine oculis-related homeobox 1 |
178 |
0.95 |
chr2_113828248_113829427 | 4.93 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr11_39793944_39795224 | 4.89 |
Gm24192 |
predicted gene, 24192 |
36072 |
0.21 |
chr6_65380864_65381898 | 4.87 |
Qrfprl |
pyroglutamylated RFamide peptide receptor like |
87 |
0.97 |
chr15_99704098_99705242 | 4.86 |
Gm34939 |
predicted gene, 34939 |
694 |
0.3 |
chr12_56680898_56682238 | 4.86 |
Pax9 |
paired box 9 |
10199 |
0.14 |
chr11_34315414_34316667 | 4.67 |
Insyn2b |
inhibitory synaptic factor family member 2B |
1218 |
0.45 |
chr1_78201086_78202244 | 4.65 |
Pax3 |
paired box 3 |
4531 |
0.25 |
chr7_131966504_131967699 | 4.61 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr8_67973559_67974885 | 4.54 |
Psd3 |
pleckstrin and Sec7 domain containing 3 |
352 |
0.89 |
chr11_114793777_114794456 | 4.52 |
Btbd17 |
BTB (POZ) domain containing 17 |
1757 |
0.26 |
chrX_57916667_57918033 | 4.49 |
Gm25023 |
predicted gene, 25023 |
72123 |
0.11 |
chr18_43686487_43688415 | 4.46 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr1_9601164_9602408 | 4.45 |
Vxn |
vexin |
587 |
0.67 |
chr5_144545163_144547007 | 4.42 |
Nptx2 |
neuronal pentraxin 2 |
183 |
0.96 |
chr5_144547334_144548656 | 4.42 |
Nptx2 |
neuronal pentraxin 2 |
2093 |
0.41 |
chr11_57011668_57012922 | 4.42 |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
339 |
0.94 |
chr12_106080982_106081684 | 4.42 |
Gm46378 |
predicted gene, 46378 |
3037 |
0.25 |
chr12_118848802_118850409 | 4.40 |
Sp8 |
trans-acting transcription factor 8 |
2019 |
0.36 |
chr19_37686376_37687814 | 4.37 |
Cyp26c1 |
cytochrome P450, family 26, subfamily c, polypeptide 1 |
1514 |
0.39 |
chr13_51918926_51919335 | 4.34 |
Gm26651 |
predicted gene, 26651 |
54084 |
0.13 |
chr3_97887925_97889043 | 4.33 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
223 |
0.92 |
chr14_54228777_54229582 | 4.30 |
Traj1 |
T cell receptor alpha joining 1 |
10365 |
0.08 |
chr3_86863698_86863923 | 4.29 |
Gm37025 |
predicted gene, 37025 |
682 |
0.7 |
chr13_81632543_81633660 | 4.28 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
38 |
0.98 |
chr8_108716860_108718878 | 4.24 |
Zfhx3 |
zinc finger homeobox 3 |
3225 |
0.3 |
chr8_122335750_122336915 | 4.23 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr5_103209022_103210413 | 4.22 |
Mapk10 |
mitogen-activated protein kinase 10 |
705 |
0.75 |
chr6_54588936_54589087 | 4.21 |
Fkbp14 |
FK506 binding protein 14 |
2910 |
0.22 |
chrX_88115387_88116599 | 4.16 |
Il1rapl1 |
interleukin 1 receptor accessory protein-like 1 |
348 |
0.92 |
chr18_61737389_61738065 | 4.12 |
1500015A07Rik |
RIKEN cDNA 1500015A07 gene |
3370 |
0.17 |
chr14_122481093_122481670 | 4.10 |
Zic2 |
zinc finger protein of the cerebellum 2 |
3281 |
0.14 |
chr3_101379658_101381123 | 4.05 |
Igsf3 |
immunoglobulin superfamily, member 3 |
2052 |
0.26 |
chr10_120721676_120722691 | 4.05 |
Gm37505 |
predicted gene, 37505 |
9632 |
0.13 |
chr16_96280491_96281572 | 4.02 |
B3galt5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
233 |
0.93 |
chr7_123983249_123983725 | 3.98 |
Gm27040 |
predicted gene, 27040 |
33 |
0.92 |
chr5_120430812_120431653 | 3.97 |
Lhx5 |
LIM homeobox protein 5 |
467 |
0.48 |
chr11_102605789_102606436 | 3.95 |
Fzd2 |
frizzled class receptor 2 |
1716 |
0.21 |
chr7_57590618_57591056 | 3.92 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
319 |
0.91 |
chr10_109010445_109010974 | 3.90 |
Syt1 |
synaptotagmin I |
253 |
0.95 |
chr2_7395418_7396363 | 3.90 |
Celf2 |
CUGBP, Elav-like family member 2 |
3 |
0.99 |
chr5_131536272_131536438 | 3.89 |
Auts2 |
autism susceptibility candidate 2 |
1615 |
0.37 |
chr10_84757399_84758243 | 3.86 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
1759 |
0.41 |
chr2_172937060_172938226 | 3.85 |
Bmp7 |
bone morphogenetic protein 7 |
2449 |
0.28 |
chr1_135372451_135373569 | 3.85 |
Shisa4 |
shisa family member 4 |
440 |
0.74 |
chr16_78930672_78931913 | 3.84 |
Chodl |
chondrolectin |
15 |
0.98 |
chr3_87949543_87950464 | 3.81 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr1_38835637_38836715 | 3.80 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
198 |
0.94 |
chr11_55607331_55608633 | 3.78 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr6_127766683_127768449 | 3.77 |
Gm42738 |
predicted gene 42738 |
24 |
0.95 |
chr2_164400211_164401393 | 3.77 |
Rbpjl |
recombination signal binding protein for immunoglobulin kappa J region-like |
2339 |
0.15 |
chr14_108910678_108911967 | 3.76 |
Slitrk1 |
SLIT and NTRK-like family, member 1 |
2836 |
0.42 |
chr5_112640559_112641459 | 3.76 |
4933415J04Rik |
RIKEN cDNA 4933415J04 gene |
674 |
0.64 |
chr3_152980951_152982389 | 3.75 |
St6galnac5 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
382 |
0.86 |
chr13_63554202_63556305 | 3.74 |
Ptch1 |
patched 1 |
8562 |
0.14 |
chr17_11067055_11068310 | 3.74 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
557 |
0.82 |
chrX_21333640_21335080 | 3.73 |
Gm6938 |
predicted gene 6938 |
367 |
0.88 |
chr14_67236008_67239452 | 3.69 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr19_60146143_60147364 | 3.67 |
E330013P04Rik |
RIKEN cDNA E330013P04 gene |
2049 |
0.34 |
chr1_158362036_158363261 | 3.67 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr4_110284889_110285145 | 3.66 |
Elavl4 |
ELAV like RNA binding protein 4 |
1599 |
0.53 |
chr6_36808050_36808542 | 3.64 |
Ptn |
pleiotrophin |
1883 |
0.46 |
chr6_140962062_140962880 | 3.61 |
Gm30524 |
predicted gene, 30524 |
6836 |
0.26 |
chr2_73277002_73278211 | 3.60 |
Sp9 |
trans-acting transcription factor 9 |
5640 |
0.17 |
chr2_27027194_27027995 | 3.59 |
Slc2a6 |
solute carrier family 2 (facilitated glucose transporter), member 6 |
315 |
0.79 |
chr7_112825291_112826896 | 3.59 |
Tead1 |
TEA domain family member 1 |
13541 |
0.24 |
chr10_69705909_69707430 | 3.58 |
Ank3 |
ankyrin 3, epithelial |
191 |
0.97 |
chr6_22875139_22876535 | 3.58 |
Ptprz1 |
protein tyrosine phosphatase, receptor type Z, polypeptide 1 |
60 |
0.98 |
chr13_97248475_97250229 | 3.57 |
Enc1 |
ectodermal-neural cortex 1 |
8247 |
0.17 |
chr13_47855217_47856285 | 3.57 |
G630093K05Rik |
RIKEN cDNA G630093K05 gene |
54684 |
0.16 |
chr7_82869041_82870364 | 3.56 |
Mex3b |
mex3 RNA binding family member B |
2369 |
0.22 |
chr8_12947702_12949640 | 3.56 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr6_54564534_54565307 | 3.56 |
Scrn1 |
secernin 1 |
1569 |
0.36 |
chr9_27790749_27791250 | 3.56 |
Opcml |
opioid binding protein/cell adhesion molecule-like |
52 |
0.99 |
chr14_122478089_122479067 | 3.55 |
Zic2 |
zinc finger protein of the cerebellum 2 |
478 |
0.68 |
chr14_66635276_66637386 | 3.55 |
Adra1a |
adrenergic receptor, alpha 1a |
775 |
0.72 |
chr5_66996781_66997624 | 3.53 |
Limch1 |
LIM and calponin homology domains 1 |
110 |
0.95 |
chr16_41532916_41533606 | 3.53 |
Lsamp |
limbic system-associated membrane protein |
158 |
0.98 |
chr14_66911778_66912249 | 3.53 |
Pnma2 |
paraneoplastic antigen MA2 |
771 |
0.58 |
chr16_16558986_16560577 | 3.52 |
Fgd4 |
FYVE, RhoGEF and PH domain containing 4 |
209 |
0.94 |
chr17_46484709_46485013 | 3.50 |
Ttbk1 |
tau tubulin kinase 1 |
566 |
0.59 |
chr3_99255907_99257438 | 3.47 |
Tbx15 |
T-box 15 |
2912 |
0.22 |
chr7_78989959_78991095 | 3.47 |
Gm26633 |
predicted gene, 26633 |
62796 |
0.08 |
chr9_43879329_43880560 | 3.46 |
Gm23326 |
predicted gene, 23326 |
26058 |
0.14 |
chr10_117675574_117676482 | 3.43 |
Cpm |
carboxypeptidase M |
135 |
0.94 |
chr11_53759327_53760434 | 3.40 |
Mir7671 |
microRNA 7671 |
3774 |
0.13 |
chr7_36679043_36680470 | 3.39 |
Gm38285 |
predicted gene, 38285 |
15682 |
0.14 |
chr8_91799626_91800355 | 3.39 |
Irx3os |
iroquois homeobox 3, opposite strand |
425 |
0.76 |
chr3_5222045_5223052 | 3.38 |
Zfhx4 |
zinc finger homeodomain 4 |
1043 |
0.46 |
chr7_79498955_79500626 | 3.38 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr6_103809934_103810942 | 3.35 |
Gm25656 |
predicted gene, 25656 |
22140 |
0.25 |
chr12_46815602_46816139 | 3.35 |
Nova1 |
NOVA alternative splicing regulator 1 |
1090 |
0.54 |
chr15_101858787_101860016 | 3.33 |
Krt1 |
keratin 1 |
8607 |
0.1 |
chr12_57575851_57576777 | 3.30 |
Ttc6 |
tetratricopeptide repeat domain 6 |
497 |
0.77 |
chr19_18888677_18889550 | 3.30 |
Trpm6 |
transient receptor potential cation channel, subfamily M, member 6 |
48476 |
0.16 |
chr13_78182240_78182762 | 3.29 |
Gm38604 |
predicted gene, 38604 |
658 |
0.61 |
chr1_163311555_163312976 | 3.28 |
Prrx1 |
paired related homeobox 1 |
1403 |
0.39 |
chr13_71958597_71960663 | 3.27 |
Irx1 |
Iroquois homeobox 1 |
197 |
0.95 |
chr12_72407756_72408968 | 3.27 |
Rtn1 |
reticulon 1 |
692 |
0.73 |
chr19_22447648_22448999 | 3.27 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr17_69969717_69970050 | 3.26 |
Dlgap1 |
DLG associated protein 1 |
462 |
0.86 |
chr8_35764855_35766218 | 3.22 |
Gm19410 |
predicted gene, 19410 |
254 |
0.86 |
chr8_32883592_32884962 | 3.21 |
Nrg1 |
neuregulin 1 |
23 |
0.99 |
chr1_132740444_132742155 | 3.19 |
Nfasc |
neurofascin |
458 |
0.83 |
chr4_116223265_116224130 | 3.19 |
Pik3r3 |
phosphoinositide-3-kinase regulatory subunit 3 |
2001 |
0.23 |
chr10_86700286_86701944 | 3.17 |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
853 |
0.34 |
chr17_15373239_15373914 | 3.14 |
Dll1 |
delta like canonical Notch ligand 1 |
496 |
0.76 |
chr16_10446635_10447407 | 3.14 |
Tvp23a |
trans-golgi network vesicle protein 23A |
123 |
0.96 |
chr13_116514424_116515376 | 3.13 |
Gm47913 |
predicted gene, 47913 |
148636 |
0.04 |
chr1_78189316_78190249 | 3.12 |
Pax3 |
paired box 3 |
7056 |
0.24 |
chr1_72826047_72827238 | 3.12 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
1320 |
0.5 |
chr14_93889749_93891606 | 3.12 |
Pcdh9 |
protocadherin 9 |
2 |
0.99 |
chr8_57836387_57837596 | 3.12 |
Galntl6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6 |
6067 |
0.24 |
chr1_14918142_14919332 | 3.11 |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
98 |
0.98 |
chr8_94995811_94996872 | 3.11 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
680 |
0.57 |
chr7_123982468_123983092 | 3.10 |
Hs3st4 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
89 |
0.91 |
chr15_85205740_85207341 | 3.08 |
Fbln1 |
fibulin 1 |
535 |
0.78 |
chr4_98106191_98107304 | 3.08 |
Gm12691 |
predicted gene 12691 |
39852 |
0.19 |
chr17_25542315_25542466 | 3.07 |
Gm33801 |
predicted gene, 33801 |
3452 |
0.1 |
chr10_69707438_69707835 | 3.06 |
Ank3 |
ankyrin 3, epithelial |
1158 |
0.65 |
chr6_104492794_104494036 | 3.06 |
Cntn6 |
contactin 6 |
167 |
0.98 |
chr2_157914223_157915670 | 3.05 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr11_60141098_60141590 | 3.04 |
Rai1 |
retinoic acid induced 1 |
1085 |
0.44 |
chr5_120435079_120435805 | 3.04 |
Gm27199 |
predicted gene 27199 |
3675 |
0.15 |
chr10_28492781_28494073 | 3.03 |
Ptprk |
protein tyrosine phosphatase, receptor type, K |
66724 |
0.13 |
chr1_91344585_91345841 | 3.03 |
Klhl30 |
kelch-like 30 |
5803 |
0.11 |
chr11_103840627_103841312 | 3.02 |
Nsf |
N-ethylmaleimide sensitive fusion protein |
13538 |
0.18 |
chr3_31309226_31310664 | 3.02 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr1_177446374_177448525 | 3.00 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr16_29837120_29837709 | 2.99 |
Gm32679 |
predicted gene, 32679 |
2686 |
0.29 |
chr7_80746141_80746557 | 2.99 |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
2469 |
0.25 |
chr8_12400578_12402091 | 2.99 |
Gm25239 |
predicted gene, 25239 |
4931 |
0.15 |
chr7_48960076_48960785 | 2.99 |
Nav2 |
neuron navigator 2 |
1333 |
0.41 |
chr14_122484555_122484706 | 2.99 |
Gm10837 |
predicted gene 10837 |
5956 |
0.11 |
chr4_123000744_123001129 | 2.98 |
Mycl |
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived |
1597 |
0.3 |
chr4_36952312_36953412 | 2.98 |
Gm12371 |
predicted gene 12371 |
104 |
0.95 |
chr5_63649182_63650439 | 2.97 |
Gm9954 |
predicted gene 9954 |
454 |
0.49 |
chr15_89840994_89842160 | 2.97 |
Syt10 |
synaptotagmin X |
283 |
0.93 |
chr13_96131908_96133176 | 2.97 |
Sv2c |
synaptic vesicle glycoprotein 2c |
35 |
0.94 |
chr13_56295365_56296328 | 2.96 |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
459 |
0.77 |
chr1_120604474_120605877 | 2.95 |
En1 |
engrailed 1 |
2757 |
0.3 |
chr4_25799045_25800424 | 2.95 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr12_67219520_67219941 | 2.94 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1312 |
0.58 |
chr2_180026738_180027280 | 2.94 |
Lsm14b |
LSM family member 14B |
611 |
0.61 |
chr9_91378153_91379783 | 2.94 |
Zic4 |
zinc finger protein of the cerebellum 4 |
326 |
0.81 |
chrX_20059587_20060936 | 2.94 |
Chst7 |
carbohydrate (N-acetylglucosamino) sulfotransferase 7 |
701 |
0.78 |
chr11_68151136_68151287 | 2.93 |
C78197 |
expressed sequence C78197 |
44942 |
0.13 |
chr14_52009953_52011160 | 2.93 |
Zfp219 |
zinc finger protein 219 |
19 |
0.94 |
chr3_101398569_101399045 | 2.93 |
Gm42939 |
predicted gene 42939 |
8986 |
0.15 |
chr7_79502506_79503035 | 2.93 |
Mir9-3 |
microRNA 9-3 |
2494 |
0.13 |
chrX_101851839_101852248 | 2.93 |
Nhsl2 |
NHS-like 2 |
2658 |
0.19 |
chr3_88213113_88214199 | 2.93 |
Gm3764 |
predicted gene 3764 |
829 |
0.3 |
chr10_60115211_60116020 | 2.93 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
9147 |
0.19 |
chr10_109832096_109833441 | 2.92 |
Nav3 |
neuron navigator 3 |
453 |
0.9 |
chr1_42697532_42698715 | 2.91 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
2355 |
0.2 |
chr3_137547447_137548472 | 2.91 |
Gm4861 |
predicted gene 4861 |
4663 |
0.24 |
chr14_122472255_122473599 | 2.91 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
652 |
0.55 |
chr11_21999153_21999972 | 2.90 |
Otx1 |
orthodenticle homeobox 1 |
2053 |
0.4 |
chr2_137112378_137113208 | 2.89 |
Jag1 |
jagged 1 |
3851 |
0.33 |
chr5_37716516_37717529 | 2.89 |
Stk32b |
serine/threonine kinase 32B |
149 |
0.96 |
chr15_78915623_78916717 | 2.88 |
Pdxp |
pyridoxal (pyridoxine, vitamin B6) phosphatase |
2251 |
0.12 |
chr12_105562813_105564183 | 2.88 |
Bdkrb2 |
bradykinin receptor, beta 2 |
272 |
0.88 |
chr4_124575007_124576219 | 2.87 |
4933407E24Rik |
RIKEN cDNA 4933407E24 gene |
6423 |
0.2 |
chr12_27341229_27342599 | 2.87 |
Sox11 |
SRY (sex determining region Y)-box 11 |
660 |
0.81 |
chr13_47942254_47942964 | 2.86 |
G630093K05Rik |
RIKEN cDNA G630093K05 gene |
32174 |
0.2 |
chr6_64733770_64735303 | 2.86 |
Atoh1 |
atonal bHLH transcription factor 1 |
5411 |
0.3 |
chr7_70325324_70326669 | 2.85 |
Gm29683 |
predicted gene, 29683 |
11826 |
0.13 |
chr18_89768830_89769936 | 2.85 |
Dok6 |
docking protein 6 |
145 |
0.97 |
chr9_41378412_41379411 | 2.84 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
2350 |
0.27 |
chr1_94035083_94036007 | 2.84 |
Neu4 |
sialidase 4 |
15052 |
0.16 |
chr11_96903326_96903603 | 2.83 |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
5294 |
0.1 |
chr10_116017652_116019652 | 2.83 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr13_78202666_78203848 | 2.83 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
470 |
0.74 |
chr7_44443183_44443767 | 2.83 |
Lrrc4b |
leucine rich repeat containing 4B |
738 |
0.4 |
chr7_140080531_140082545 | 2.83 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr4_83656591_83657293 | 2.82 |
Ccdc171 |
coiled-coil domain containing 171 |
39013 |
0.14 |
chr10_73099097_73100287 | 2.81 |
Pcdh15 |
protocadherin 15 |
239 |
0.94 |
chr8_31917541_31918367 | 2.80 |
Nrg1 |
neuregulin 1 |
288 |
0.81 |
chr3_154663659_154664932 | 2.80 |
Erich3 |
glutamate rich 3 |
436 |
0.82 |
chr4_22667767_22668038 | 2.80 |
Gm11879 |
predicted gene 11879 |
36155 |
0.19 |
chr10_120564701_120565278 | 2.79 |
Gm24298 |
predicted gene, 24298 |
40548 |
0.14 |
chr17_25781962_25783700 | 2.79 |
Mir6966 |
microRNA 6966 |
2023 |
0.09 |
chr15_20448699_20449797 | 2.79 |
Cdh12 |
cadherin 12 |
17 |
0.53 |
chr5_129052825_129053470 | 2.79 |
Ran |
RAN, member RAS oncogene family |
32875 |
0.15 |
chr6_28980713_28981850 | 2.79 |
Gm3294 |
predicted gene 3294 |
353 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 11.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.3 | 6.8 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
2.1 | 8.4 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.0 | 8.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.0 | 6.0 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
1.9 | 3.8 | GO:0060594 | mammary gland specification(GO:0060594) |
1.9 | 7.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.9 | 9.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
1.9 | 7.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.8 | 7.3 | GO:0030035 | microspike assembly(GO:0030035) |
1.8 | 9.1 | GO:0060174 | limb bud formation(GO:0060174) |
1.8 | 10.9 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.8 | 5.3 | GO:0072235 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.8 | 8.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.7 | 5.0 | GO:0021586 | pons maturation(GO:0021586) |
1.7 | 6.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.6 | 8.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.6 | 4.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.6 | 4.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.6 | 4.7 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
1.6 | 4.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.5 | 6.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.5 | 3.0 | GO:0048880 | sensory system development(GO:0048880) |
1.5 | 3.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.5 | 4.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.5 | 4.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.4 | 1.4 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.4 | 4.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.4 | 1.4 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.3 | 5.4 | GO:0007412 | axon target recognition(GO:0007412) |
1.3 | 4.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.3 | 5.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.3 | 4.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.3 | 6.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.3 | 4.0 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.3 | 9.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.3 | 6.5 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.3 | 3.9 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.3 | 5.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.3 | 5.1 | GO:0097491 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
1.3 | 3.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.3 | 3.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.2 | 3.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 12.3 | GO:0060013 | righting reflex(GO:0060013) |
1.2 | 3.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.2 | 4.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.2 | 3.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.2 | 2.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.2 | 1.2 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 9.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.2 | 13.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.2 | 2.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.1 | 3.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
1.1 | 3.4 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
1.1 | 2.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
1.1 | 4.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.1 | 3.4 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.1 | 4.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.1 | 1.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
1.1 | 3.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 4.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.1 | 1.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) |
1.1 | 3.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.1 | 2.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.1 | 1.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.1 | 1.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
1.1 | 3.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 1.1 | GO:0060166 | olfactory pit development(GO:0060166) |
1.0 | 3.1 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.0 | 1.0 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.0 | 3.1 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.0 | 3.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.0 | 3.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.0 | 5.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.0 | 4.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 2.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.0 | 6.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.0 | 2.0 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.0 | 3.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 1.9 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
1.0 | 7.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 3.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.0 | 1.9 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.9 | 2.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.9 | 3.8 | GO:0014060 | regulation of epinephrine secretion(GO:0014060) |
0.9 | 2.8 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.9 | 10.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 3.7 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.9 | 2.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.9 | 3.7 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.9 | 7.3 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.9 | 4.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 2.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.9 | 4.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.9 | 2.7 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.9 | 0.9 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.9 | 2.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.9 | 1.7 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.9 | 7.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.9 | 3.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.9 | 6.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.8 | 2.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.8 | 4.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.8 | 2.5 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.8 | 2.5 | GO:0072017 | distal tubule development(GO:0072017) |
0.8 | 1.7 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.8 | 0.8 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.8 | 0.8 | GO:0072174 | metanephric tubule formation(GO:0072174) |
0.8 | 2.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.8 | 2.5 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.8 | 1.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.8 | 2.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.8 | 2.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.8 | 1.6 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.8 | 1.6 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.8 | 9.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.8 | 3.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.8 | 2.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.8 | 3.9 | GO:0046958 | nonassociative learning(GO:0046958) |
0.8 | 3.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.8 | 3.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.8 | 2.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.8 | 2.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 3.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.8 | 3.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 4.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.8 | 0.8 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.8 | 0.8 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
0.8 | 2.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.8 | 3.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.8 | 13.5 | GO:0001964 | startle response(GO:0001964) |
0.8 | 7.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 2.2 | GO:0060437 | lung growth(GO:0060437) |
0.7 | 1.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.7 | 9.0 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.7 | 3.0 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.7 | 3.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.7 | 3.7 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 | 3.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.7 | 2.9 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 0.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.7 | 2.9 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 2.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 2.2 | GO:0060618 | nipple development(GO:0060618) |
0.7 | 1.4 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.7 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.7 | 2.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 1.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.7 | 1.4 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.7 | 0.7 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.7 | 20.2 | GO:0019228 | neuronal action potential(GO:0019228) |
0.7 | 2.1 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.7 | 2.1 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.7 | 1.4 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.7 | 4.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.7 | 10.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.7 | 1.4 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.7 | 0.7 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.7 | 1.4 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.7 | 4.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.7 | 3.4 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.7 | 1.3 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.7 | 0.7 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.7 | 1.3 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.7 | 2.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.7 | 2.6 | GO:0033504 | floor plate development(GO:0033504) |
0.7 | 3.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.7 | 2.0 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.7 | 1.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.6 | 1.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.6 | 2.6 | GO:0048664 | neuron fate determination(GO:0048664) |
0.6 | 2.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 2.6 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.6 | 2.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.6 | 1.3 | GO:0009629 | response to gravity(GO:0009629) |
0.6 | 1.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.6 | 1.8 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.6 | 1.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 4.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 4.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.6 | 1.8 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.6 | 1.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.6 | 1.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 2.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.6 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.6 | 0.6 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.6 | 4.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 5.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 1.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.6 | 1.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 0.6 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.6 | 1.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.6 | 2.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 1.7 | GO:0048840 | otolith development(GO:0048840) |
0.6 | 1.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 28.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 0.6 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.6 | 7.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.5 | 1.1 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.5 | 1.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.5 | 2.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 1.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.5 | 1.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 1.1 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 0.5 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.5 | 1.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 0.5 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.5 | 1.6 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 0.5 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.5 | 1.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.5 | 1.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 1.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.5 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.6 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 1.0 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.5 | 1.0 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 1.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.5 | 0.5 | GO:0061548 | ganglion development(GO:0061548) |
0.5 | 2.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 0.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.5 | 3.0 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.5 | 1.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.5 | 1.5 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 4.0 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.5 | 2.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 2.0 | GO:0014028 | notochord formation(GO:0014028) |
0.5 | 0.5 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 2.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 1.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.5 | 0.5 | GO:0060157 | urinary bladder development(GO:0060157) |
0.5 | 0.5 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.5 | 1.9 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.5 | 0.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.5 | 14.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 1.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.5 | 1.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.5 | 1.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 2.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 6.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.5 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.5 | 0.9 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.5 | 2.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.5 | 1.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 1.4 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 | 0.9 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.5 | 0.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.4 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 1.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.4 | 0.9 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 4.0 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.4 | 4.8 | GO:0060384 | innervation(GO:0060384) |
0.4 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 0.9 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.4 | 4.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.4 | 0.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.4 | 1.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.4 | 1.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.4 | 1.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 0.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.4 | 0.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.4 | 0.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.4 | 1.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.4 | 0.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 1.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 1.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 2.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 0.4 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.4 | 1.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 0.4 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.4 | 0.4 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.4 | 4.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.4 | 0.8 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.8 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 7.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 0.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 0.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.6 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 1.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.4 | 1.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 1.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.4 | 0.4 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.4 | 1.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.4 | 1.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 2.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 1.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 4.2 | GO:0036065 | fucosylation(GO:0036065) |
0.4 | 1.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.4 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.4 | 1.5 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 0.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 6.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.4 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 0.4 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 1.8 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.4 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 2.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 0.7 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 3.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.4 | 1.5 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.4 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 3.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.4 | 1.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 1.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 1.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 0.4 | GO:0021546 | rhombomere development(GO:0021546) |
0.4 | 2.5 | GO:0060068 | vagina development(GO:0060068) |
0.4 | 0.4 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 0.4 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
0.3 | 2.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.7 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.3 | 3.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.0 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.3 | 1.0 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.3 | 0.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 2.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 1.7 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.3 | 0.7 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 1.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.3 | 1.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 1.0 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.3 | 1.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 4.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 3.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 3.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 0.3 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.3 | 1.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 1.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.3 | 0.3 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.6 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 1.6 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.3 | 0.6 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 1.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.3 | 5.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.3 | 2.8 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 0.6 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 0.3 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.3 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.3 | 0.3 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 0.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 0.6 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.3 | 1.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 0.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 1.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.3 | 1.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.3 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.9 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 1.2 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.3 | 0.9 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 5.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 1.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.3 | 0.6 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.3 | 0.3 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.3 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 1.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.3 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.3 | 1.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 0.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.3 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.3 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 0.9 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.3 | 0.6 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.3 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.3 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 2.0 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.3 | 0.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 0.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.3 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 1.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 1.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 17.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.9 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.5 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 0.3 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.3 | 2.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 8.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.3 | 2.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 2.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.3 | 0.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 0.8 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.3 | 0.5 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.3 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.3 | 0.5 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.3 | 0.5 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.3 | 0.3 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.3 | 0.5 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 1.5 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.3 | 0.5 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.3 | 2.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 3.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 1.5 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.2 | 3.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.2 | 0.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.5 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.5 | GO:0099612 | protein localization to axon(GO:0099612) |
0.2 | 0.2 | GO:0098597 | observational learning(GO:0098597) |
0.2 | 2.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 0.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 0.7 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 0.7 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 2.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.2 | 0.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 2.8 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 3.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.2 | 0.2 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 0.7 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.2 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.9 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 2.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 2.9 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 1.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 0.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 0.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 1.5 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.2 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.2 | 0.9 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.9 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 3.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.6 | GO:0061623 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.4 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.2 | GO:0032222 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) regulation of synaptic transmission, cholinergic(GO:0032222) acetylcholine secretion(GO:0061526) |
0.2 | 0.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.4 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 1.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.2 | 1.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 11.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.2 | GO:0033034 | positive regulation of neutrophil apoptotic process(GO:0033031) positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.2 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 2.2 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.2 | 0.8 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.2 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 1.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 0.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.2 | 1.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.4 | GO:0043465 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.8 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 1.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 0.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.4 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.2 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 5.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 0.2 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.2 | 1.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.2 | 1.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 0.7 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.2 | 0.5 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.2 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.5 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.2 | 3.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 1.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.2 | 1.9 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.2 | 1.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.2 | GO:0061525 | hindgut development(GO:0061525) |
0.2 | 0.2 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 0.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 6.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.2 | 0.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.2 | 2.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 1.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 0.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.2 | 2.5 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 1.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 1.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.3 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 1.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.2 | 0.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.2 | 0.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.2 | 0.8 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 0.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 2.1 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.2 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.2 | 0.3 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.2 | 3.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 0.3 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.2 | 0.3 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 0.9 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 0.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 2.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.3 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.2 | 0.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.5 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 0.4 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 0.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.1 | 0.6 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.3 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.6 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.3 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.1 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.7 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 1.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.4 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.5 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.1 | 0.3 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.1 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.1 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 1.3 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.1 | 0.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.1 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 1.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 1.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.5 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 1.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 0.9 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.0 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 1.0 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.1 | 0.9 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 2.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.2 | GO:1903333 | regulation of protein refolding(GO:0061083) negative regulation of protein folding(GO:1903333) |
0.1 | 0.2 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.6 | GO:0007616 | long-term memory(GO:0007616) |
0.1 | 0.1 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0043584 | nose development(GO:0043584) |
0.1 | 5.9 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.1 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.1 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.1 | 0.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 5.3 | GO:0007612 | learning(GO:0007612) |
0.1 | 2.5 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.9 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
0.1 | 0.1 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.1 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.4 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.4 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 0.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.3 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
0.1 | 0.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.2 | GO:0002568 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 2.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 1.8 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.4 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 1.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.5 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.1 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 6.0 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.1 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.3 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.1 | GO:1902074 | response to salt(GO:1902074) |
0.1 | 1.1 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.3 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.2 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.3 | GO:0061245 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.7 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.2 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.9 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 2.8 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 0.1 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.5 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 1.0 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.1 | 1.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 0.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.1 | 0.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.1 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
0.1 | 0.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 5.0 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.1 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 2.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.4 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.2 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 0.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.3 | GO:0060004 | reflex(GO:0060004) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.9 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.1 | 0.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 3.1 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.3 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0022605 | oogenesis stage(GO:0022605) |
0.1 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.1 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.1 | 0.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.1 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.1 | 0.3 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.2 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 1.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 0.4 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.2 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.1 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.8 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0034331 | cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.1 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0021544 | subpallium development(GO:0021544) |
0.0 | 0.3 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 0.1 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.2 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.0 | 0.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 0.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.1 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.1 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.0 | 0.0 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.0 | 0.3 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.0 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.0 | 0.3 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.0 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.1 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.0 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
0.0 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.2 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.0 | 0.0 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.0 | 0.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.2 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.0 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.1 | GO:1990696 | USH2 complex(GO:1990696) |
1.4 | 2.8 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.4 | 4.2 | GO:0072534 | perineuronal net(GO:0072534) |
1.4 | 4.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.4 | 4.1 | GO:0044393 | microspike(GO:0044393) |
1.2 | 4.9 | GO:0044308 | axonal spine(GO:0044308) |
1.0 | 1.0 | GO:0035838 | growing cell tip(GO:0035838) |
1.0 | 4.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 10.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.9 | 17.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.9 | 1.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.9 | 8.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.9 | 3.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 2.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 14.3 | GO:0030673 | axolemma(GO:0030673) |
0.8 | 3.1 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.8 | 6.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.8 | 2.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 5.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.8 | 2.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.7 | 2.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.7 | 33.7 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.7 | 0.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 1.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 9.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 1.8 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 3.5 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.6 | 0.6 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.6 | 2.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 2.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.5 | 12.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.5 | 0.5 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.5 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 3.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.5 | 1.5 | GO:1990635 | proximal dendrite(GO:1990635) |
0.5 | 2.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 17.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 67.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 6.5 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 0.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.5 | 14.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 3.7 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 3.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 1.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 23.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 11.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 0.8 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 1.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 4.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 1.1 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.4 | 2.2 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 2.9 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 0.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 3.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.3 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 2.0 | GO:0005883 | neurofilament(GO:0005883) |
0.3 | 2.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.3 | 1.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 4.4 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 24.0 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.3 | 1.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 1.1 | GO:1990745 | EARP complex(GO:1990745) |
0.3 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 2.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.3 | 3.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 2.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 2.8 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 1.0 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 3.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 3.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 6.0 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.7 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 1.2 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 28.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 4.6 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.4 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.2 | 2.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 2.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 3.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.0 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.4 | GO:0034705 | potassium channel complex(GO:0034705) |
0.2 | 0.8 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 14.9 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 1.2 | GO:0002177 | manchette(GO:0002177) |
0.2 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 3.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 1.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 3.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 0.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 0.5 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 2.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 1.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.2 | 1.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.2 | 0.5 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 5.7 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 1.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 2.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 2.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 3.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.1 | 0.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 1.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 1.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 1.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 0.6 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 1.0 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.1 | 0.7 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 1.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.6 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 2.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 10.1 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 0.8 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.9 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 3.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.9 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 13.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 15.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.1 | GO:0030891 | VCB complex(GO:0030891) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.5 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 0.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.0 | 2.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0034703 | cation channel complex(GO:0034703) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.0 | 0.0 | GO:0071439 | clathrin complex(GO:0071439) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.1 | 6.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.8 | 5.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.8 | 7.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
1.6 | 4.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.5 | 4.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.4 | 8.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.3 | 5.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.3 | 5.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.3 | 2.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.3 | 2.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.2 | 3.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 1.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.2 | 5.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.2 | 5.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.1 | 3.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.1 | 6.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 5.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.1 | 1.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.1 | 9.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.0 | 5.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.0 | 3.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
1.0 | 3.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.0 | 2.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.0 | 5.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.0 | 6.9 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 3.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.0 | 2.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 2.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.9 | 8.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 3.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.8 | 2.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.8 | 2.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 2.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 2.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.8 | 14.1 | GO:0005112 | Notch binding(GO:0005112) |
0.8 | 7.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.8 | 2.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.8 | 3.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.8 | 4.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 3.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.7 | 14.1 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.7 | 2.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 7.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.7 | 2.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.7 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.7 | 4.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.7 | 0.7 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 2.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.7 | 2.6 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 2.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 3.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.7 | 24.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 1.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.6 | 1.9 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.6 | 7.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 3.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 1.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 3.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 13.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 7.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.6 | 4.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 2.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.6 | 1.8 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.6 | 3.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 7.5 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.6 | 2.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.6 | 2.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.6 | 2.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 1.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.6 | 2.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 2.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 2.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 1.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.5 | 3.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.5 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 1.6 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.5 | 1.6 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 2.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 2.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 0.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.5 | 2.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.5 | 5.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.5 | 1.9 | GO:0097001 | ceramide binding(GO:0097001) |
0.5 | 4.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.5 | 0.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.5 | 2.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 6.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.4 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.4 | 2.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 0.9 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.4 | 1.3 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.4 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 3.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.4 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 2.5 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 1.7 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.4 | 3.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 1.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.4 | 0.4 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.4 | 1.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 2.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.4 | 4.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.4 | 2.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 1.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 1.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.4 | 8.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.4 | 1.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 1.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 2.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.4 | 1.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.4 | 3.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 5.4 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 0.8 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.4 | 2.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 2.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 1.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 7.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 1.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 1.9 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 9.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.4 | 1.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 1.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.4 | 6.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 0.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 5.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.4 | 5.5 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 5.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 2.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 0.4 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.4 | 8.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 3.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.4 | 1.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 1.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.4 | 5.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 2.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 2.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.3 | 1.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.3 | 4.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 2.0 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 3.7 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.3 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 1.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 2.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.3 | 3.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 6.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 1.3 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 7.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.9 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 4.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 9.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.3 | 0.9 | GO:0018557 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.3 | 8.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 2.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.3 | 1.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 3.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 0.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 1.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 1.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 2.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.3 | 1.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 3.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 6.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 1.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 3.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.6 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 1.1 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 0.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.3 | 3.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 1.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.3 | 2.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 4.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 2.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 0.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 3.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 2.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 7.2 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 9.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.2 | 0.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 0.9 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.2 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 5.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 2.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 2.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.6 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 6.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 2.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.7 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.2 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.2 | 1.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 3.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.5 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
0.2 | 0.2 | GO:0005119 | smoothened binding(GO:0005119) |
0.2 | 0.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 0.3 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.2 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.5 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 1.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 1.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 3.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 2.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 7.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 7.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 1.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 25.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 2.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.9 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.9 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 1.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 2.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.3 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 59.7 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 2.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 9.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0018501 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.2 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 0.6 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.5 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 2.1 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 4.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.3 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 1.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 1.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 1.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 1.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 1.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 0.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.2 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.1 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.2 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 1.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 26.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.1 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 0.4 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 0.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 1.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0052623 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 1.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.2 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.0 | 4.6 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 1.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.0 | 0.2 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 1.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.4 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.0 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 1.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.1 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.0 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.1 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 21.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 10.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 1.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 4.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.6 | 1.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 15.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 6.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.5 | 7.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 12.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 10.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 3.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 0.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 18.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 4.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 12.5 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 5.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 5.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 4.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 7.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 3.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 31.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 8.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.2 | 2.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 3.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 7.1 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 4.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 4.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 1.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 2.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.8 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.0 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 11.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.0 | 14.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.0 | 1.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.8 | 2.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.8 | 12.1 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.8 | 16.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 7.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.7 | 8.9 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.6 | 5.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 16.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.6 | 6.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 1.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.6 | 6.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 6.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 7.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 6.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 5.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 11.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.4 | 3.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 8.5 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 8.7 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.4 | 2.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 9.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 32.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 6.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 6.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 11.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 3.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 4.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 5.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 2.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 1.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 3.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 12.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 2.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.3 | 2.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 0.8 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.3 | 4.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 3.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 4.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 1.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 1.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 4.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 3.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 0.9 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.2 | 1.2 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 2.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 21.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 3.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 0.6 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
0.1 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 2.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 0.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.1 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.0 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |